World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
59110
World Ranking
17779
National Ranking
746

Overview

Morris Sherman is affiliated with the University Health Network in Canada and specializes in the field of medicine with a strong focus on epidemiology and hepatology. Their research is particularly centered on liver disease diagnosis and treatment, hepatitis B and C virus studies, and hepatocellular carcinoma treatment and prognosis. Their work also touches on liver disease and transplantation as well as cancer genomics and diagnostics.

The scientist has contributed to a range of publications in various medical journals. Frequent publication venues include:

  • JHEP Reports
  • Gastroenterology
  • Hepatology Communications
  • Hepatology
  • Liver International

Morris Sherman's recent papers highlight significant topics in liver disease and cancer research. Among these are:

  • International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma, 2021, Gastroenterology
  • A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma, 2022, Hepatology Communications
  • What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association, 2022, JHEP Reports
  • The viral hepatitis B care cascade: A population-based comparison of immigrant groups, 2021, Hepatology
  • Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents, 2021, Liver International

The scientist frequently collaborates with other researchers in related fields. Their notable coauthors include:

  • Jordan J. Feld
  • Yujin Hoshida
  • Abdool S. Yasseen
  • Jeffrey C. Kwong
  • Rafal Kustra

Morris Sherman's subfields of study are distributed across epidemiology, hepatology, cancer research, pharmacology, and surgery, illustrating a multidisciplinary approach within medical sciences. Their focus on epidemiology includes 15 publications, while hepatology accounts for 9, complemented by work in cancer research.

The main topics of Morris Sherman's scientific work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Cancer, Lipids, and Metabolism
  • Cancer Genomics and Diagnostics

Best Publications

  • Management of hepatocellular carcinoma: An update

    Jordi Bruix;Morris Sherman

  • Management of hepatocellular carcinoma.

    Jordi Bruix;Morris Sherman

  • Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

    Jordi Bruix;Maria Reig;Morris Sherman

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

    L Bolondi;S Sofia;S Siringo;S Gaiani

  • Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

    Alexis Bujold;Christine A. Massey;John J. Kim;James Brierley

  • Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

    Josep M. Llovet;Thomas Decaens;Jean-Luc Raoul;Eveline Boucher

  • Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

    Regina V. Tse;Maria Hawkins;Gina Lockwood;John J. Kim

  • Tivantinib for second-line treatment of advanced hepatocellular carcinoma: A randomised, placebo-controlled phase 2 study

    Armando Santoro;Lorenza Rimassa;Ivan Borbath;Bruno Daniele

  • Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.

    Morris Sherman;Cihan Yurdaydin;Jose Sollano;Marcelo Silva

  • LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions

    Donald G. Mitchell;Jordi Bruix;Morris Sherman;Claude B. Sirlin

  • Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.

    Peter R Galle;Friedrich Foerster;Masatoshi Kudo;Stephen L Chan

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • The role of hepatic resection in the treatment of hepatocellular cancer

    Sasan Roayaie;Ghalib Jibara;Parissa Tabrizian;Joong Won Park

  • Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naïve Genotype 1 Hepatitis C: The Randomized PILLAR Study

    Michael W. Fried;Maria Buti;Gregory J. Dore;Robert Flisiak

  • Hepatocellular Carcinoma (HCC): A Global Perspective

    Peter Ferenci;Michael Fried;Douglas Labrecque;Jordi Bruix

  • Strategies to manage hepatitis C virus (HCV) disease burden

    H Wedemeyer;A S Duberg;M Buti;W M Rosenberg

Frequent Co-Authors

Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Mel Krajden
Mel Krajden University of British Columbia
Paul D. Greig
Paul D. Greig Toronto General Hospital
Masao Omata
Masao Omata University of Tokyo
Richard S. Finn
Richard S. Finn University of California, Los Angeles
Mark W. Tyndall
Mark W. Tyndall University of British Columbia
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Soo Young Park
Soo Young Park Seoul National University
Zahid A Butt
Zahid A Butt University of Waterloo
Ronnie T.P. Poon
Ronnie T.P. Poon University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in healthcare but are exploring alternatives to studying Medicine in the USA, online degrees offer flexible and accessible paths. For those wanting to enter the workforce quickly, fast track lpn programs are ideal for starting a practical nursing career in less time.

For nurses seeking to specialize further, the fastest psychiatric nurse practitioner program options allow RNs to advance rapidly into mental health and psychiatric care roles.

Not all healthcare careers require direct patient care. A management track can begin with the cheapest online healthcare administration degree, which equips students with business and leadership skills necessary for running clinics or hospitals.

For even greater advancement, consider the cheapest mha online programs. A master’s in healthcare administration opens opportunities for executive and policy-making positions as you help shape the future of healthcare delivery in the US.

Best Scientists Citing Morris Sherman

Trending Scientists